Medicine Supplier to South Africa Under Section 21
Among all African countries, South Africa has the most organized and patient-focused regulatory systems. Generally, a medicine has to be registered before it can be marketed or sold. However, the South African system understands that people suffering from serious or rare conditions cannot always wait for long periods for the lengthy approval timelines. This is
Read more →
Global Access to Unapproved Drugs
In some scenarios, patients around the world need unlicensed or unapproved medicines. This happens when standard treatments have failed or are not yet available in their home country. Healthcare is changing quickly, and Global Access to Unapproved Drugs is becoming important, as new medicines are approved every year by authorities like the U.S. FDA, EMA,
Read more →
Reference Listed Drugs (RLDs): Procurement and Supply Chain
What Are Reference Listed Drugs (RLDs), and Why Do They Matter? A Reference Listed Drug (RLD) is the original medicine approved by regulatory authorities such as the FDA or EMA. It serves as the official benchmark against which generic medicines are tested for safety, quality, and efficacy. In the pharmaceutical industry, the Reference Listed Drug
Read more →
The Importance of a Global RLD Supplier in Clinical Research Success
A Global RLD Supplier plays an important role in clinical research and drug development to be successful.As drug research and development continue to advance, the success of any clinical research project depends largely on the availability, authenticity, and compliance of the therapeutic drug that is currently in the trial. Therefore, access to Reference Listed Drugs
Read more →
Clinical Trial Materials Supply:Navigating Clinical Trials with Precision and Expertise
Clinical Trial Sourcing is essential for the success of every clinical trial, providing timely access to drugs, comparator materials, and all necessary ancillary supplies. Efficient management of these materials ensures that studies run smoothly, results are reliable, and regulatory requirements are met. At the forefront of medical innovation, clinical trials depend on a seamless supply
Read more →
Sourcing the Standard: The Importance of RLDs in Clinical Trials
Reference Listed Drugs (RLDs) are brand-name medications that have been approved by regulatoryagencies, such as the FDA or EMA, and serve as the benchmark for evaluating the safety, efficacy, andquality of generic or biosimilar products. They play a crucial role in the pharmaceutical industry,particularly in the development and approval of generic drugs and biosimilars. Role
Read more →
Pharmaceutical Exports: Global Market Trends & Insights
India has emerged as the world’s biggest exporter of generic medicines, commanding an enormous share of the global export market. The Indian pharmaceutical industry has witnessed remarkable advancement in areas such as infrastructure upgradation and technological advancements. This growth has propelled India to the forefront of the generic medicines export landscape, human resources, producing a
Read more →
Ikris Health+: Revolutionizing Access to Vital Medical Information
In today’s digital era, instant access to pharmaceutical services is crucial. The Ikris Health+ app by Ikris Pharma Network meets this need by providing healthcare professionals, researchers, and patients with a comprehensive tool for accessing vital medical information and services. From sourcing rare disease treatments to managing named patient programs, Ikris Health+ streamlines healthcare management,
Read more →
Bridging Global Healthcare with Reliable Pharmaceutical Solutions
As a trusted generic medicine supplier from India, Ikris Pharma Network is bridging global healthcare with reliable pharmaceutical solutions. Founded in 2014 and headquartered in Noida, India, we have grown into a leading pharmaceutical exporter known for supplying high-quality generic and branded medicines worldwide. By delivering affordable treatments and specialized Pharma services, Ikris Pharma International
Read more →